Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC nicotine patches

This article was originally published in The Tan Sheet

Executive Summary

Use of SmithKline Beecham's NicoDerm CQ smoking cessation patch (21 mg) results in better heart rate variability (HRV) among post-MI patients than individuals randomized to a placebo patch, Phyllis Stein, Washington University School of Medicine, et al., report in a poster presented at the ACC meeting in Anaheim March 12-15. The study compared the HRV effect of smoking cessation among 18 people - nine wearing the NicoDerm patch and nine the placebo - for a four-week period. Holter recordings were taken at baseline and at the end of the month. "Smoking cessation using transdermal nicotine patches compared with quitting cold turkey resulted in more 'favorable' changes in HRV," the researchers state. The findings suggest the need for further study in a larger population, Stein et al. conclude
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS091000

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel